Adverse safety events in chronic kidney disease: The frequency of "Multiple Hits"

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 1, 2010, Pages 95-101

  Chapin, Erica ^a   Zhan, Min ^a   Hsu, Van Doren ^b   Seliger, Stephen L ^a   Walker, Loreen D ^b   Fink, Jeffrey C ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH CARE QUALITY; HUMAN; HYPERKALEMIA; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; PATIENT SAFETY; RISK FACTOR;

AGED; CHRONIC DISEASE; FEMALE; HUMANS; KIDNEY DISEASES; MALE; MEDICATION ERRORS; RETROSPECTIVE STUDIES; RISK FACTORS; SAFETY;

EID: 75749158570     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06210909     Document Type: Article

References (15)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the united states. JAMA 298: 2038-2047, 2007
2. Seliger SL, Zhan M, Hsu VD, Walker LD, Fink JC: Chronic kidney disease adversely influences patient safety. J Am Soc Nephrol 19: 2414-2419, 2008
3. Rosen AK, Zhao S, Rivard P, Loveland S, Montez-Rath ME, Elixhauser A, Romano PS: Tracking rates of patient safety indicators over time: Lessons from the veterans administration. Med Care 44: 850-861, 2006
4. Friedman B, Encinosa W, Jiang HJ, Mutter R: Do patient safety events increase readmissions? Med Care 47: 583-590, 2009
5. Cowper DC, Hynes DM, Kubal JD, Murphy PA: Using administrative databases for outcomes research: Select examples from VA health services research and development. J Med Syst 23: 249-259, 1999
6. Maynard C, Chapko MK: Data resources in the department of veterans affairs. Diabetes Care 27[Suppl 2]: B22-B26, 2004
7. Moen MF, Zhan M, Hsu VD, Walker LD, Einhorn LM, Seliger SL, Fink JC: Frequency of hypoglycemia and its significance in chronic kidney disease. Clin J Am Soc Nephrol 4: 1121-1127, 2009
8. Einhorn LM, Zhan M, Hsu VD, Walker LD, Moen MF, Seliger SL, Weir MR, Fink JC: The frequency of hyperkalemia and its significance in chronic kidney disease. Arch Intern Med 169: 1156-1162, 2009
9. Levey AS, Greene T, Kusek JW, Beck GJ: A simplified equation to predict glomerular filtration rate from serum creatinine [Abstract]. J Am Soc Nephrol 111: 115A, 2000
10. Stevens LA, Coresh J, Greene T, Levey AS: Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 354: 2473-2483, 2006
11. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39: S1-S266, 2002
12. Aronoff GR, Berns JS, Brier ME, Golper TA, Morrison G, Singer I, Swan SK, Bennett WM: Drug Prescribing in Renal Failure: Dosing Guidelines for Adults, 4th ed., Philadelphia, American College of Physicians, 1999
13. Kerr EA, Fleming B: Making performance indicators work: Experiences of U.S. Veterans Health Administration. BMJ 335: 971-973, 2007
14. Corsonello A, Pedone C, Corica F, Mussi C, Carbonin P, Antonelli Incalzi R: Gruppo Italiano di Farmacovigilanza nell'Anziano (GIFA) Investigators: Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients. Arch Intern Med 165: 790-795, 2005
15. Meyer GS, Battles J, Hart JC, Tang N: The US agency for healthcare research and quality's activities in patient safety research. Int J Qual Health Care 15[Suppl 1]: i25-i30, 2003